Immunocore/$IMCR
About Immunocore
Ticker
Industry
Employees
Immunocore Metrics
$1.4B
-
-$0.95
0.72
-
Price and volume
Market cap
$1.4B
Beta
0.72
52-week high
$76.98
52-week low
$27.69
Average daily volume
289K
Financial strength
Current ratio
3.778
Quick ratio
3.624
Long term debt to equity
114.274
Total debt to equity
127.324
Interest coverage (TTM)
-5.26%
Management effectiveness
Return on assets (TTM)
-5.22%
Return on equity (TTM)
-12.83%
Valuation
Price to revenue (TTM)
4.806
Price to book
3.78
Price to tangible book (TTM)
3.78
Price to free cash flow (TTM)
71.66
Growth
Revenue change (TTM)
25.09%
Earnings per share change (TTM)
-32.96%
3-year revenue growth (CAGR)
100.70%
3-year earnings per share growth (CAGR)
-37.93%
What the Analysts think about Immunocore
Analyst Ratings
Immunocore Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Immunocore Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Immunocore News
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
FAQs
What’s the current market cap for Immunocore stock?
What is the P/E ratio for Immunocore stock?
Does Immunocore stock pay dividends?
No, Immunocore (IMCR) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Immunocore dividend payment date?
Immunocore (IMCR) stock does not pay dividends to its shareholders.
What is the beta indicator for Immunocore?
Immunocore (IMCR) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.